Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole

Anticancer Res. 2007 Sep-Oct;27(5B):3477-80.

Abstract

Low grade endometrial stromal sarcoma (LGESS) is a rare disease. LGESS usually expresses steroidal receptors and is regarded to be hormone-sensitive. Due to the rarity of the tumor, only few case series have been published so far. Here, we report the case of a 36-year-old woman who underwent an abdominal hysterectomy with bilateral salpingo-oophorectomy and adjuvant radiotherapy for a G1 LGESS in 1991. Twelve years later she presented to us with pelvic and peritoneal masses. The patient was treated with letrozole achieving a partial response which is lasting 39 months. Treatment is ongoing. Aromatase inhibitors represent an interesting treatment option for LGESS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Endometrial Stromal Tumors / drug therapy*
  • Endometrial Stromal Tumors / pathology
  • Endometrial Stromal Tumors / prevention & control*
  • Female
  • Humans
  • Letrozole
  • Muscle Neoplasms / secondary
  • Nitriles / therapeutic use*
  • Psoas Muscles / pathology
  • Radiography, Abdominal
  • Recurrence
  • Tomography, X-Ray Computed
  • Triazoles / therapeutic use*

Substances

  • Antineoplastic Agents
  • Nitriles
  • Triazoles
  • Letrozole